Here are three things to know about Dr. Califf.
1. He joined the FDA as deputy commissioner earlier this year from Durham, N.C.-based Duke University, where he had served as a professor of medicine, a leading pharmaceutical researcher and the vice chancellor for clinical and translational research.
2. He has led many pivotal clinical trials, been among the most cited medical authors in the U.S. and for years served on various FDA advisory committees, according to the report.
3. If confirmed by the U.S. Senate, Dr. Califf will replace Stephen Ostroff, MD, who has served as acting commissioner since Margaret Hamburg, MD, stepped down earlier this year.
More articles on leadership and management:
KishHealth System CEO honored with AHA Grassroots Champions Award
Donald Trump calls CEO pay ‘a complete joke’
When’s the best time of day to take a break?
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.